Company Valuation: Clinitech Laboratory Limited

Data adjusted to current consolidation scope
Fiscal Period: March 2025 2026
Market Cap 1 91.84 79.88
Change - -13.02%
Enterprise Value (EV) 1 61.1 64.14
Change - 4.98%
P/E 21.2x 19.1x
PBR 1.04x 0.86x
PEG -1.1x -5.48x
Capitalization / Revenue 1.12x 0.84x
EV / Revenue 0.74x 0.68x
EV / EBITDA 7.34x 6.31x
EV / EBIT 16x 12.6x
EV / FCF - -
FCF Yield - -
Dividend per Share 2 - -
Rate of return - -
EPS 2 1.896 1.83
Distribution rate - -
Net sales 1 82.35 94.91
EBITDA 1 8.319 10.16
EBIT 1 3.821 5.079
Net income 1 3.947 4.179
Net Debt 1 -30.75 -15.75
Reference price 2 40.24 35.00
Nbr of stocks (in thousands) 2,282 2,282
Announcement Date 26/08/25 22/08/26
1INR in Million2INR
Estimates


P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
- - - - 755K
12.8x0.39x8.23x3.02% 112B
14.84x1.84x9.22x0.71% 95.08B
-279.8x19.23x-326.91x-.--% 57.02B
13.21x1.46x8.81x2.7% 27.29B
22.39x2.06x11.83x0.93% 25.3B
22.34x2.51x12.71x1.45% 25.06B
31.2x5.66x23.5x2.23% 21.27B
7.89x1.43x6.47x-.--% 20.92B
20.4x1.82x9.16x3.41% 19.35B
Average -14.97x 4.04x -26.33x 1.61% 40.38B
Weighted average by Cap. -25.74x 4.10x -37.56x 1.62%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Clinitech Laboratory Limited

Historical PBR trend

Valuation ratios - PBR - Clinitech Laboratory Limited

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Clinitech Laboratory Limited

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Clinitech Laboratory Limited

  1. Stock Market
  2. Stocks
  3. 544220 Stock
  4. Valuation Clinitech Laboratory Limited